[go: up one dir, main page]

WO2014149985A1 - Cellulase and phytase inhibitor - Google Patents

Cellulase and phytase inhibitor Download PDF

Info

Publication number
WO2014149985A1
WO2014149985A1 PCT/US2014/021734 US2014021734W WO2014149985A1 WO 2014149985 A1 WO2014149985 A1 WO 2014149985A1 US 2014021734 W US2014021734 W US 2014021734W WO 2014149985 A1 WO2014149985 A1 WO 2014149985A1
Authority
WO
WIPO (PCT)
Prior art keywords
cellulase
phytase
inhibitor
enzyme
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2014/021734
Other languages
French (fr)
Inventor
Cristina POP
Yi Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Enzymes LLC
Original Assignee
Verenium Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verenium Corp filed Critical Verenium Corp
Publication of WO2014149985A1 publication Critical patent/WO2014149985A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F265/00Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
    • C08F265/04Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of esters
    • C08F265/06Polymerisation of acrylate or methacrylate esters on to polymers thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Definitions

  • Cellulase, phytase, xylanase, and amylase enzymes have a variety of known industrial uses including, but not limited to: oil well fracturing, animal feed additives, detergents, baking, manufacturing biofuels, etc.
  • One of the challenges of using enzymes in these harsh industrial processes is to ensure that the enzyme is active at the right time under the optimal conditions, such as temperature or pH, for the enzymes characteristics. Therefore, a need exists to find an inhibitor for cellulase, phytase, xylanase, and amylase enzymes that will work under industrial conditions, which are much different than conditions required for the pharmaceutical industry.
  • enzymes can be inhibited by the binding of specific small molecules and ions.
  • Enzyme inhibition can be reversible or irreversible. Irreversible inhibitors dissociates relatively slowly from the enzyme because the inhibitor has become either covalently or non-covalently bond to the enzyme. Reversible inhibition dissociates relatively quickly from the enzyme-inhibitor complex.
  • Reversible inhibition can be competitive inhibition, non-competitive inhibition, or mixed inhibition.
  • competitive inhibition the enzyme can bind substrate or the enzyme can bind with an inhibitor, but the enzyme cannot bind with both the substrate and the inhibitor.
  • non-competitive inhibition the inhibitor and the substrate can bind to the enzyme molecule at different binding sites. Non-competitive inhibition cannot be overcome by increasing the substrate concentration.
  • mixed inhibition a single inhibitor both hinders the binding of substrate and decreases the turnover number of the enzyme.
  • starch-g-poly(acrylic acid) copolymers and starch/poly (acrylic acid) mixtures have an inhibition potency for trypsin, which plays a key role in initiating the degradation of orally administered peptide drugs and in activating the zymogen forms of a lot of pancreatic peptidases.
  • trypsin inhibition calcium and zinc ion binding of starch-g-poly(acrylic acid) copolymers and starch/poly(acrylic acid) mixtures for peroral peptide drug deliver
  • Carbopol 934 which is a cross-linked polyacrylic acid, was shown to inhibit R A-dependent DNA polymerase (reverse transcriptase) of Rauscher Murine Leukemia Virus (R-MuLV) and Avian Myoblastosis Virus (AMV); however, stimulation of enzymatic activity by Carbopol is not a property shared by all reverse transcriptases. See, Bloemers, "Inhibition of RNA-dependent DNA polymerase of OncoRNA viruses by Carbopol 934.
  • a cross-linked polyacrylic acid such as Carbopol can be an inhibitor of some proteases, and DNA polymerases
  • a cross-linked copolymer of acrylic acid and C10-C30 alkyl acrylate such as PEMULEN Polymers from Lubrizol Corporation, inhibit a cellulase, phytase, xylanase, or amylase enzymes.
  • a cross-linked copolymers for inhibition of a cellulase, phytase, xylanase, or amylase enzymes has several advantages: 1) it is a reversible inhibitor, allowing activity recovery upon inhibitor dilution or dialysis; 2) it is a potent inhibitor, requiring small dosage for complete inhibition; 3) it seems to provide specific inhibition of cellulases or phytases, but not amylases and xylanases; 4) it is an emulsion stabilizer, and therefore it can serve a dual role when used in an emulsion formulation for controlled release, i.e., stabilizing the emulsion system, and further delaying the enzyme activity in addition to the encapsulation effect from the emulsion; 5) it may also be used in combination with other controlled release formulations, e.g., microencapsulation, nanoencapsulation, to improve the effect of delaying enzyme activity; this is based on the requirement of the dilution
  • Figure 1 shows that Pemulen is a potent inhibitor of Cellulase and Phytase.
  • Figure 2A-2D show that Pemulen 1622 does not influence the standard curves of detection method below 1000 ug/mL.
  • Figure 3A-3B shows that Pemulen 1622 is a reversible inhibitor of Phytase
  • Figure 4 shows that Pemulenl621 is a reversible potent inhibitor of Cellulase.
  • Figure 5 shows that Aculin22 and Carbopol ETD 2623 also inhibit Cellulase.
  • Figure 6 shows Pemulen inhibition of Cellulase at pH 5-9. DETAILED DESCRIPTION OF THE INVENTION
  • Cellulase is an enzyme that catalyzes a reaction of endo-hydrolysis of 1,4-beta-D- glycosidic linkages in cellulose, lichenin, and cereal beta-D-glucans (such as barley beta-glucan). Since the predominant activities of the disclosed cellulase of the present invention are the endo- hydrolysis of barley beta-glucan and carboxymethyl cellulose, it is appropriately ascribed the IUBMB Enzyme Nomenclature EC 3.2.1.4. Other names used for enzymes belonging to this group include: endoglucanase, endo-l,4-beta-glucanase, carboxymethyl cellulase, and beta- 1,4- glucanase.
  • the cellulase can be a cellulase or a variant of a cellulase disclosed in patent number: US 5,962,258, US 6,008,032, US 6,245,547, US 7,807,433, or international patent publication number WO 2009/020459.
  • the cellulase can be a commercially available product including, but not limited to PYROLASE cellulase (Verenium).
  • Phytase is a phosphoric monoester hydrolase enzyme that catalyzes hydrolysis of phytic acid (myo-inositol-hexakisphosphate) to phosphorus and inositol. According to the recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB) and Bairoch A., "The ENZYME database in 2000," Nucleic Acids Res 28:304-305(2000), a phytase is classified as Enzyme Commission (EC) number EC 3.1.3.8, and is also referred to as: 1-phytase; myo-inositol-hexakisphosphate 3- phosphohydrolase; phytate 1 -phosphatase; phytate 3 -phosphatase; or phytate 6-phosphatase.
  • EC Enzyme Commission
  • Phytase is also classified as EC 3.1.3.26, which is also referred to as: 4-phytase; 6-phytase (name based on lL-numbering system and not ID-numbering); or phytate 6-phosphatase.
  • Phytase is also classified as EC 3.1.3.72, which is also referred to as 5-phytase.
  • Phytase is also referred to as histidine acid phosphatases (HAP); ⁇ -propeller phytases; purple acid phosphatase (PAP); and protein tyrosine phosphatases (PTPs).
  • HAP histidine acid phosphatases
  • PAP purple acid phosphatase
  • PTPs protein tyrosine phosphatases
  • Alternative names for phytase will be known to those skilled in the art.
  • the phytase is a phytase, or a phytase variant disclosed in International PCT Publication Number: WO 1999/008539, WO 2000/071728, WO 2001/090333, WO 2002/095003, WO 2006/028684, WO 2008/036916, or WO 2010/135588.
  • the phytase is a commercially available phytase including but not limited to: PHYZYME (Dupont, Danisco, Genencor); QUANTUM and FINASE (AB Vista, AB Enzymes); NATUPHOS (BASF); RONOZYME (DSM); BIOFEED PHYTASE (Novo Nordisk); ALLZYME PHYTASE (Alltech); OPTIPHOS (Enzyvia, Phytex, Cornell); ROVABIO (Adisseo); and PHYTOUT (US Waters).
  • Xylanase (endo-1, 4-beta-xylanase, EC 3.2.1.8) is an enzyme that hydrolyze internal ⁇ - 1 ,4-xylosidic linkages in xylan to produce smaller molecular weight xylose and xylo-oligomers.
  • Xylans are polysaccharides formed from 1 ,4-P-glycoside-linked D-xylopyranoses.
  • Amylase is polypeptide or peptide having multiple enzyme activities including the ability to hydrolyze internal alpha- 1 ,4-glucosidic linkages in starch to produce smaller molecular weight malto-dextrins.
  • the a-amylase activity includes hydro lyzing internal alpha- 1,4-glucosidic linkages in starch at random.
  • the Amylase is a glucoamylase activity, a 1 ,4-a-D-glucan glucohydrolase activity, an exoamylase activity, or a ⁇ - amylase activity.
  • the amylase activity can comprise hydrolyzing glucosidic bonds.
  • the glucosidic bonds comprise an a- 1,4-glucosidic bond. In another aspect, the glucosidic bonds comprise an a-l,6-glucosidic bond.
  • the amylase activity comprises hydrolyzing glucosidic bonds in starch, e.g., liquefied starch. The amylase activity can further comprise hydrolyzing glucosidic bonds into maltodextrins. In one aspect, the amylase activity comprises cleaving a maltose or a D-glucose unit from non-reducing end of the starch.
  • Pemulen 1622 polymer is a high molecular weight, crosslinked copolymer of acrylic acid and C10-C30 alkyl acrylate that is designed to form stable oil-in-water emulsions. It has relatively low viscosity compared to other Carbopol polymers
  • Pemulen 1621 polymer is a high molecular weight, crosslinked copolymer of acrylic acid and C10-C30 alkyl acrylate that is designed to form stable oil-in-water emulsions. It has relatively medium viscosity compared to other Pemulen polymers.
  • Carbopol ETD 2623 polymer is a hydrophobically modified, crosslinked polyacrylate powder.
  • Aculin 22 is an anionic hydrophobically-modified Alkali Soluble Emulsion (HASE).
  • a reversible enzyme inhibitor is a polymer with an inhibition constant (Kj) below 1 ug/mL range, wherein the enzyme is selected from a group consisting of: a phytase, a cellulase, a xylanase, and an amylase.
  • the reversible enzyme inhibitor is a polymer, wherein the polymer is a cross-linked co-polymer comprising an acrylic acid and a C10-C30 alkyl acrylate.
  • a reversible cellulase inhibitor is a composition comprising an acrylic acid and a C10-C30 alkyl acrylate with an inhibition constant ( ⁇ ;) below 1 ug/mL range.
  • a reversible phytase inhibitor is a composition comprising an acrylic acid and a C10-C30 alkyl acrylate with an inhibition constant (Kj) below 1 ug/mL range.
  • a formulation comprising: (a) a cellulase or a phytase; (b) an acrylic acid; and (c) a C10-C30 alkyl acrylate.
  • a formulation is used in a gas or oil well fluid. In another embodiment, the formulation is used as an additive for an animal feed. In another embodiment, the formulation is used in a detergent. In another embodiment, the formulation is used in baking. In another embodiment, the formulation is used in the manufacturing of bio fuels.
  • Pemulenl622 inhibited activities of Cellulase I and Cellulase II at concentrations above 0.5 ug/mL ( Figure 1), without interfering with the spectroscopic properties of the detection assay ( Figure 2).
  • Pemulen 1621 (Lubrizol), structurally similar to Pemulen 1622 (Lubrizol), was also shown to be a potent inhibitor of Cellulase I ( Figure 4).
  • Carbopol ETD 2623 and Aculin 22, which are both structurally similar to Pemulein 1621 and Pemulen 1622 were also shown to be inhibitors of Cellulase I; however, these inhibitors were lower potency inhibitors of Cellulase I when compared to the inhibition potency of Pemulen 1622 and Pemulen 1621 ( Figure 5).
  • Negative control enzymes - Xylanase I, Xylanase II, and Amylase I were used in similar conditions together with proper substrates 2% wheat arabinoxylan (Megazyme) and, respectively, 1% corn starch (Sigma). Glucose, mannose, and xylose standard curves were generated in presence and absence of Pemulenl622 (Lubrizol).
  • Pemulenl622 did not inhibit activity of Amylase I in the specified range.
  • Pemulen 1622 did not inhibit activity of Xylanase I and Xylanase II at concentrations above 500 ug/mL ( Figure 1).
  • Example 2 Cellulase inhibition as a function of pH in PNP assay
  • Phytase I at 6 ug/mL was mixed with Pemulen 1622 (Lubrizol) at concentrations between 0.024-200,000 ng/niL in 50 mM Na-acetate pH 5.0 and incubated at room temperature for 15 min. Enzyme control did not contain Pemulenl622. Samples were diluted 20 fold into 4 mM Phytic acid (Sigma) plus 50 mM Na-acetate pH 4.5, containing no Pemulen 1622 or containing the same amounts of Pemulenl622 (Lubrizol) as the stock solution. Activity was determined by phosphate colorimetric assay at 50°C, by stopping the reaction every 2 min and reading the absorbance at 415 nm. Phosphate standard curve was generated in presence and absence of Pemulenl622 (Lubrizol).
  • Pemulenl622 inhibited activity of Phytase I at concentrations above 0.5 ug/mL ( Figure 1), without interfering with the spectroscopic properties of the detection assay ( Figure 2).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

At acidic and neutral pH, Pemulen 1622 inhibited Cellulase and Phytase from hydrolyze their substrates, beta-glucan and phytic acid, respectively, without interfering with the spectroscopic method of detection. Previously, the mechanism of inhibition has been unknown, but experiments suggested that Pemulen 1622 decreased the concentration of available substrate or it bound competitively to the enzyme active site.

Description

CELLULASE AND PHYTASE INHIBITOR TECHNICAL FIELD
Natural and synthetic inhibitors of enzymes have been previously described especially in the pharmaceutical industry; however, enzyme inhibitors for cellulase, phytase, xylanase, and amylase enzymes are generally scarce.
Cellulase, phytase, xylanase, and amylase enzymes have a variety of known industrial uses including, but not limited to: oil well fracturing, animal feed additives, detergents, baking, manufacturing biofuels, etc. One of the challenges of using enzymes in these harsh industrial processes is to ensure that the enzyme is active at the right time under the optimal conditions, such as temperature or pH, for the enzymes characteristics. Therefore, a need exists to find an inhibitor for cellulase, phytase, xylanase, and amylase enzymes that will work under industrial conditions, which are much different than conditions required for the pharmaceutical industry.
Generally, it is understood in the art that enzymes can be inhibited by the binding of specific small molecules and ions. Enzyme inhibition can be reversible or irreversible. Irreversible inhibitors dissociates relatively slowly from the enzyme because the inhibitor has become either covalently or non-covalently bond to the enzyme. Reversible inhibition dissociates relatively quickly from the enzyme-inhibitor complex. Reversible inhibition can be competitive inhibition, non-competitive inhibition, or mixed inhibition. In competitive inhibition, the enzyme can bind substrate or the enzyme can bind with an inhibitor, but the enzyme cannot bind with both the substrate and the inhibitor. In non-competitive inhibition, the inhibitor and the substrate can bind to the enzyme molecule at different binding sites. Non-competitive inhibition cannot be overcome by increasing the substrate concentration. In mixed inhibition, a single inhibitor both hinders the binding of substrate and decreases the turnover number of the enzyme.
Previously, it has been shown in vitro that starch-g-poly(acrylic acid) copolymers and starch/poly (acrylic acid) mixtures have an inhibition potency for trypsin, which plays a key role in initiating the degradation of orally administered peptide drugs and in activating the zymogen forms of a lot of pancreatic peptidases. See, Ameye, et. al. "Trypsin inhibition, calcium and zinc ion binding of starch-g-poly(acrylic acid) copolymers and starch/poly(acrylic acid) mixtures for peroral peptide drug deliver" Journal of Controlled Release 75 (2001) 357-364. In another study, Carbopol 934, which is a cross-linked polyacrylic acid, was shown to inhibit R A-dependent DNA polymerase (reverse transcriptase) of Rauscher Murine Leukemia Virus (R-MuLV) and Avian Myoblastosis Virus (AMV); however, stimulation of enzymatic activity by Carbopol is not a property shared by all reverse transcriptases. See, Bloemers, "Inhibition of RNA-dependent DNA polymerase of OncoRNA viruses by Carbopol 934.
Although, it has been previously reported that a cross-linked polyacrylic acid, such as Carbopol can be an inhibitor of some proteases, and DNA polymerases, it has not been previously reported or suggested that a cross-linked copolymer of acrylic acid and C10-C30 alkyl acrylate, such as PEMULEN Polymers from Lubrizol Corporation, inhibit a cellulase, phytase, xylanase, or amylase enzymes.
As shown herein, using a cross-linked copolymers for inhibition of a cellulase, phytase, xylanase, or amylase enzymes has several advantages: 1) it is a reversible inhibitor, allowing activity recovery upon inhibitor dilution or dialysis; 2) it is a potent inhibitor, requiring small dosage for complete inhibition; 3) it seems to provide specific inhibition of cellulases or phytases, but not amylases and xylanases; 4) it is an emulsion stabilizer, and therefore it can serve a dual role when used in an emulsion formulation for controlled release, i.e., stabilizing the emulsion system, and further delaying the enzyme activity in addition to the encapsulation effect from the emulsion; 5) it may also be used in combination with other controlled release formulations, e.g., microencapsulation, nanoencapsulation, to improve the effect of delaying enzyme activity; this is based on the requirement of the dilution of the polymer upon enzyme release that needs to reach below the inhibition threshold. BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING
Figure 1 : shows that Pemulen is a potent inhibitor of Cellulase and Phytase.
Figure 2A-2D: show that Pemulen 1622 does not influence the standard curves of detection method below 1000 ug/mL.
Figure 3A-3B: shows that Pemulen 1622 is a reversible inhibitor of Phytase and
Cellulase.
Figure 4: shows that Pemulenl621 is a reversible potent inhibitor of Cellulase.
Figure 5 : shows that Aculin22 and Carbopol ETD 2623 also inhibit Cellulase.
Figure 6: shows Pemulen inhibition of Cellulase at pH 5-9. DETAILED DESCRIPTION OF THE INVENTION
"Cellulase" is an enzyme that catalyzes a reaction of endo-hydrolysis of 1,4-beta-D- glycosidic linkages in cellulose, lichenin, and cereal beta-D-glucans (such as barley beta-glucan). Since the predominant activities of the disclosed cellulase of the present invention are the endo- hydrolysis of barley beta-glucan and carboxymethyl cellulose, it is appropriately ascribed the IUBMB Enzyme Nomenclature EC 3.2.1.4. Other names used for enzymes belonging to this group include: endoglucanase, endo-l,4-beta-glucanase, carboxymethyl cellulase, and beta- 1,4- glucanase.
In an embodiment, the cellulase can be a cellulase or a variant of a cellulase disclosed in patent number: US 5,962,258, US 6,008,032, US 6,245,547, US 7,807,433, or international patent publication number WO 2009/020459. In another embodiment the cellulase can be a commercially available product including, but not limited to PYROLASE cellulase (Verenium).
"Phytase" is a phosphoric monoester hydrolase enzyme that catalyzes hydrolysis of phytic acid (myo-inositol-hexakisphosphate) to phosphorus and inositol. According to the recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB) and Bairoch A., "The ENZYME database in 2000," Nucleic Acids Res 28:304-305(2000), a phytase is classified as Enzyme Commission (EC) number EC 3.1.3.8, and is also referred to as: 1-phytase; myo-inositol-hexakisphosphate 3- phosphohydrolase; phytate 1 -phosphatase; phytate 3 -phosphatase; or phytate 6-phosphatase. Phytase is also classified as EC 3.1.3.26, which is also referred to as: 4-phytase; 6-phytase (name based on lL-numbering system and not ID-numbering); or phytate 6-phosphatase. Phytase is also classified as EC 3.1.3.72, which is also referred to as 5-phytase. Phytase is also referred to as histidine acid phosphatases (HAP); β-propeller phytases; purple acid phosphatase (PAP); and protein tyrosine phosphatases (PTPs). Alternative names for phytase will be known to those skilled in the art.
In an embodiment, the phytase is a phytase, or a phytase variant disclosed in International PCT Publication Number: WO 1999/008539, WO 2000/071728, WO 2001/090333, WO 2002/095003, WO 2006/028684, WO 2008/036916, or WO 2010/135588.
In another embodiment, the phytase is a commercially available phytase including but not limited to: PHYZYME (Dupont, Danisco, Genencor); QUANTUM and FINASE (AB Vista, AB Enzymes); NATUPHOS (BASF); RONOZYME (DSM); BIOFEED PHYTASE (Novo Nordisk); ALLZYME PHYTASE (Alltech); OPTIPHOS (Enzyvia, Phytex, Cornell); ROVABIO (Adisseo); and PHYTOUT (US Waters).
"Xylanase" (endo-1, 4-beta-xylanase, EC 3.2.1.8) is an enzyme that hydrolyze internal β- 1 ,4-xylosidic linkages in xylan to produce smaller molecular weight xylose and xylo-oligomers. Xylans are polysaccharides formed from 1 ,4-P-glycoside-linked D-xylopyranoses.
"Amylase" is polypeptide or peptide having multiple enzyme activities including the ability to hydrolyze internal alpha- 1 ,4-glucosidic linkages in starch to produce smaller molecular weight malto-dextrins. In one aspect, the a-amylase activity includes hydro lyzing internal alpha- 1,4-glucosidic linkages in starch at random. In another embodiment, the Amylase is a glucoamylase activity, a 1 ,4-a-D-glucan glucohydrolase activity, an exoamylase activity, or a β- amylase activity. The amylase activity can comprise hydrolyzing glucosidic bonds. In one aspect, the glucosidic bonds comprise an a- 1,4-glucosidic bond. In another aspect, the glucosidic bonds comprise an a-l,6-glucosidic bond. In one aspect, the amylase activity comprises hydrolyzing glucosidic bonds in starch, e.g., liquefied starch. The amylase activity can further comprise hydrolyzing glucosidic bonds into maltodextrins. In one aspect, the amylase activity comprises cleaving a maltose or a D-glucose unit from non-reducing end of the starch.
Pemulen 1622 polymer is a high molecular weight, crosslinked copolymer of acrylic acid and C10-C30 alkyl acrylate that is designed to form stable oil-in-water emulsions. It has relatively low viscosity compared to other Carbopol polymers
Pemulen 1621 polymer is a high molecular weight, crosslinked copolymer of acrylic acid and C10-C30 alkyl acrylate that is designed to form stable oil-in-water emulsions. It has relatively medium viscosity compared to other Pemulen polymers.
Carbopol ETD 2623 polymer is a hydrophobically modified, crosslinked polyacrylate powder.
Aculin 22 is an anionic hydrophobically-modified Alkali Soluble Emulsion (HASE). Acrylic acid (IUPAC: prop-2-enoic acid) is an organic compound with the formula CH2=CHC02H. It is the simplest unsaturated carboxylic acid, consisting of a vinyl group connected directly to a carboxylic acid terminus. Acrylic acid is also known as 2-Propenoic acid; Acroleic acid; glacial; Ethylenecarboxylic acid; Propenoic acid; Vinylformic acid. Acrylates/C10-C30 Alkyl acrylate crosspolymer
In one embodiment, a reversible enzyme inhibitor is a polymer with an inhibition constant (Kj) below 1 ug/mL range, wherein the enzyme is selected from a group consisting of: a phytase, a cellulase, a xylanase, and an amylase.
In another embodiment, the reversible enzyme inhibitor is a polymer, wherein the polymer is a cross-linked co-polymer comprising an acrylic acid and a C10-C30 alkyl acrylate.
In another embodiment, a reversible cellulase inhibitor is a composition comprising an acrylic acid and a C10-C30 alkyl acrylate with an inhibition constant (Κ;) below 1 ug/mL range.
In another embodiment, a reversible phytase inhibitor is a composition comprising an acrylic acid and a C10-C30 alkyl acrylate with an inhibition constant (Kj) below 1 ug/mL range.
In another embodiment, a formulation comprising: (a) a cellulase or a phytase; (b) an acrylic acid; and (c) a C10-C30 alkyl acrylate.
In another embodiment, a formulation is used in a gas or oil well fluid. In another embodiment, the formulation is used as an additive for an animal feed. In another embodiment, the formulation is used in a detergent. In another embodiment, the formulation is used in baking. In another embodiment, the formulation is used in the manufacturing of bio fuels.
All numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification are to be understood as being modified in all instances by the term "about." Accordingly, unless indicated to the contrary, the numerical parameters set forth herein are approximations that may vary depending upon the desired properties sought to be obtained. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of any claims in any application claiming priority to the present application, each numerical parameter should be construed in light of the number of significant digits and ordinary rounding approaches.
The above description discloses several methods and materials of the present invention. This invention is susceptible to modifications in the methods and materials, as well as alterations in the fabrication methods and equipment. Such modifications will become apparent to those skilled in the art from a consideration of this disclosure or practice of the invention disclosed herein. Consequently, it is not intended that this invention be limited to the specific embodiments disclosed herein, but that it cover all modifications and alternatives coming within the true scope and spirit of the invention. All references cited herein, including but not limited to published and unpublished applications, patents, and literature references, are incorporated herein by reference in their entirety and are hereby made a part of this specification. To the extent publications and patents or patent applications incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material. EXAMPLES Example 1 : Cellulase inhibition:
Cellulase I and Cellulase II at 20 ug/mL was mixed with Pemulenl622 (Lubrizol) at concentrations between 0.024-200,000 ng/mL (w/v) in 50 mM Na-acetate pH 5.0 and incubated at room temperature for 15 min. Enzyme control did not contain Pemulenl622 (Lubrizol). Samples were diluted 20 fold into 1% beta-glucan (Megazyme) plus 50 mM Na-acetate pH 5.0 containing no Pemulenl622 (Lubrizol) or containing the same amounts of Pemulenl622 (Lubrizol) as the stock solution. Activity was determined by DNS assay at 80°C, by stopping the reaction every 2 min, heating the plate at 80°C, followed by absorbance reading at 540 nm.
Pemulenl622 (Lubrizol) inhibited activities of Cellulase I and Cellulase II at concentrations above 0.5 ug/mL (Figure 1), without interfering with the spectroscopic properties of the detection assay (Figure 2).
Cellulase I recovered the enzymatic activity upon inhibitor dilution (Figure 3). These results, suggest that the mechanism of Cellulase inhibition was reversible.
Pemulen 1621 (Lubrizol), structurally similar to Pemulen 1622 (Lubrizol), was also shown to be a potent inhibitor of Cellulase I (Figure 4).
Carbopol ETD 2623 and Aculin 22, which are both structurally similar to Pemulein 1621 and Pemulen 1622 were also shown to be inhibitors of Cellulase I; however, these inhibitors were lower potency inhibitors of Cellulase I when compared to the inhibition potency of Pemulen 1622 and Pemulen 1621 (Figure 5).
Negative control enzymes - Xylanase I, Xylanase II, and Amylase I were used in similar conditions together with proper substrates 2% wheat arabinoxylan (Megazyme) and, respectively, 1% corn starch (Sigma). Glucose, mannose, and xylose standard curves were generated in presence and absence of Pemulenl622 (Lubrizol).
Pemulenl622 (Lubrizol) did not inhibit activity of Amylase I in the specified range. On the other hand, Pemulen 1622 (Lubrizol) produced mild inhibition for Xylanase I and Xylanase II at concentrations above 500 ug/mL (Figure 1). Example 2: Cellulase inhibition as a function of pH in PNP assay
Cellulase I (lU/mL) was incubated with Pemulen 1622 at the specified concentrations and pH 5-9 (acetate, citrate, Hepes, Tris, Bis-Tris). Samples were incubated at RT for 15 min, then diluted 10 fold into 2 mM PNP-glucopyranoside with same Pemulen 1622 (Lubrizol)
concentration and pH. Activity was measured at 65°C, reading absorbance at 405 nm.
Percentage of maximum activity (positive control= enzyme with no inhibitor) was plotted versus Pemulen 1622 concentration.
The results, shown in Figure 6, indicate that Pemulen 1622 (Lubrizol) inhibits Cellulase activity with high potency below about pH6 and with low potency above about pH7. Example 3: Phytase inhibition:
Phytase I at 6 ug/mL was mixed with Pemulen 1622 (Lubrizol) at concentrations between 0.024-200,000 ng/niL in 50 mM Na-acetate pH 5.0 and incubated at room temperature for 15 min. Enzyme control did not contain Pemulenl622. Samples were diluted 20 fold into 4 mM Phytic acid (Sigma) plus 50 mM Na-acetate pH 4.5, containing no Pemulen 1622 or containing the same amounts of Pemulenl622 (Lubrizol) as the stock solution. Activity was determined by phosphate colorimetric assay at 50°C, by stopping the reaction every 2 min and reading the absorbance at 415 nm. Phosphate standard curve was generated in presence and absence of Pemulenl622 (Lubrizol).
Pemulenl622 (Lubrizol) inhibited activity of Phytase I at concentrations above 0.5 ug/mL (Figure 1), without interfering with the spectroscopic properties of the detection assay (Figure 2).
Phytase I recovered the enzymatic activity upon inhibitor dilution (Figure 3). These results, suggest that the mechanism of Phytase inhibition was reversible.

Claims

CLAIMS What is claimed is:
1. A reversible enzyme inhibitor comprising: a polymer with an inhibition constant (Κ;) below 1 ug/mL, wherein the enzyme is a phytase or a cellulase.
2. The reversible enzyme inhibitor of claim 1 , wherein the polymer is a cross-linked co-polymer comprising an acrylic acid and a C10-C30 alkyl acrylate.
3. A reversible cellulase inhibitor comprising an acrylic acid and a C10-C30 alkyl acrylate, wherein the inhibitor has an inhibition constant (Ki) below 1 ug/mL.
4. A reversible phytase inhibitor comprising an acrylic acid and a C10-C30 alkyl acrylate, wherein the inhibitor has an inhibition constant (Ki) below 1 ug/mL.
5. A formulation comprising:
(a) a cellulase or a phytase;
(b) an acrylic acid; and
(c) a C10-C30 alkyl acrylate.
6. The formulation of claim 5, wherein the formulation is used is an industrial process comprising: a gas or oil well fluid; an animal feed additive; a detergent, a baking ingredient, or a bio fuel manufacturing process.
PCT/US2014/021734 2013-03-15 2014-03-07 Cellulase and phytase inhibitor Ceased WO2014149985A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361800490P 2013-03-15 2013-03-15
US61/800,490 2013-03-15
GB1309574.0 2013-05-29
GB1309574.0A GB2512148A (en) 2013-03-15 2013-05-29 Cellulase and phytase inhibitor

Publications (1)

Publication Number Publication Date
WO2014149985A1 true WO2014149985A1 (en) 2014-09-25

Family

ID=48784842

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/021734 Ceased WO2014149985A1 (en) 2013-03-15 2014-03-07 Cellulase and phytase inhibitor

Country Status (2)

Country Link
GB (1) GB2512148A (en)
WO (1) WO2014149985A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175579A1 (en) * 2004-02-10 2005-08-11 Koganov Michael M. Methods and compositions for the treatment of inflammation
US20060094747A1 (en) * 2004-10-28 2006-05-04 The Institute For Pharmaceutical Discovery, L.L.C. Substituted carboxylic acids
US20080107619A1 (en) * 2006-11-06 2008-05-08 University Of Florida Research Foundation, Inc. Carbohydrate based cellulase inhibitors as feeding stimulants in termites

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844102A (en) * 1994-07-07 1998-12-01 University Of Maryland Baltimore County Glycohydrolase inhibitors, their preparation and use thereof
US5912408A (en) * 1995-06-20 1999-06-15 The Procter & Gamble Company Dry cleaning with enzymes
US5783537A (en) * 1996-03-05 1998-07-21 Kay Chemical Company Enzymatic detergent composition and method for degrading and removing bacterial cellulose
US6326344B1 (en) * 2000-01-27 2001-12-04 Ecolab Inc. Carpet spot removal composition
EP1917981A1 (en) * 2006-10-30 2008-05-07 Tex-A-Tec AG Combined adsorption and dispensing system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175579A1 (en) * 2004-02-10 2005-08-11 Koganov Michael M. Methods and compositions for the treatment of inflammation
US20060094747A1 (en) * 2004-10-28 2006-05-04 The Institute For Pharmaceutical Discovery, L.L.C. Substituted carboxylic acids
US20080107619A1 (en) * 2006-11-06 2008-05-08 University Of Florida Research Foundation, Inc. Carbohydrate based cellulase inhibitors as feeding stimulants in termites

Also Published As

Publication number Publication date
GB2512148A (en) 2014-09-24
GB201309574D0 (en) 2013-07-10

Similar Documents

Publication Publication Date Title
Badhan et al. Production of multiple xylanolytic and cellulolytic enzymes by thermophilic fungus Myceliophthora sp. IMI 387099
Glass et al. Plant cell wall deconstruction by ascomycete fungi
Sanz et al. Expression of an α‐1, 3‐glucanase during mycoparasitic interaction of Trichoderma asperellum
Wang et al. Characterization of a novel thermostable β-glucosidase from a metagenomic library of termite gut
Huy et al. Characterization of a recombinant bifunctional xylosidase/arabinofuranosidase from Phanerochaete chrysosporium
Liao et al. Insights into high-efficiency lignocellulolytic enzyme production by Penicillium oxalicum GZ-2 induced by a complex substrate
Ichinose et al. Increased production of biomass-degrading enzymes by double deletion of creA and creB genes involved in carbon catabolite repression in Aspergillus oryzae
Anasontzis et al. Effects of temperature and glycerol and methanol‐feeding profiles on the production of recombinant galactose oxidase in Pichia pastoris
Franco-Cirigliano et al. Streptomyces misionensis PESB‐25 produces a thermoacidophilic endoglucanase using sugarcane bagasse and corn steep liquor as the sole organic substrates
CN103275955B (en) Xylosidase Xyl43B with high xylose tolerance, and gene and application thereof
de Gouvêa et al. Lytic polysaccharide monooxygenase from Aspergillus fumigatus can improve enzymatic cocktail activity during sugarcane bagasse hydrolysis
Agrawal et al. Discovery and expression of thermostable LPMOs from thermophilic fungi for producing efficient lignocellulolytic enzyme cocktails
Azadian et al. Purification and biochemical properties of a thermostable, haloalkaline cellulase from Bacillus licheniformis AMF-07 and its application for hydrolysis of different cellulosic substrates to bioethanol production
BR112020007814A2 (en) processes to reduce and / or prevent an increase in lactic acid levels in a biofuel fermentation system and to produce a fermentation product from a material containing starch, and, use of a polypeptide, or an enzyme composition
RU2018132952A (en) BAKING LIPASES
Kirikyali et al. Heterologous expression and kinetic characterisation of Neurospora crassa β-xylosidase in Pichia pastoris
CA3004990A1 (en) Method of producing proteins in filamentous fungi with decreased clr2 activity
Okolo et al. Purification and some properties of a novel raw starch‐digesting amylase from Aspergillus carbonarius
Del Moral et al. Production and biochemical characterization of α-glucosidase from Aspergillus niger ITV-01 isolated from sugar cane bagasse
Wu et al. Characterization of a novel alkali-stable and salt-tolerant α-amylase from marine bacterium Zunongwangia profunda
Chen et al. Characterization and homologous overexpression of an N-acetylglucosaminidase Nag1 from Trichoderma reesei
Gao et al. Biochemical characterization of a new β-glucosidase (Cel3E) from Penicillium piceum and its application in boosting lignocelluloses bioconversion and forming disaccharide inducers: New insights into the role of β-glucosidase
Lee et al. Purification and characterization of a thermostable endo-β-1, 4-glucanase from a novel strain of Penicillium purpurogenum
Tanaka et al. Starch-degrading enzymes from the brown-rot fungus Fomitopsis palustris
WO2014149985A1 (en) Cellulase and phytase inhibitor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14767496

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14767496

Country of ref document: EP

Kind code of ref document: A1